CyBio AG Plans Rights Issue in a Ratio of 3:1

(PresseBox) ( Jena, )
On October 12, 2009, the Executive Board of CyBio AG (Deutsche Boerse: General Standard, ISIN-Number DE0005412308), has, with today's approval by the Supervisory Board, made use of the authorization granted by the Annual Shareholder's Meeting on May 15, 2007 to implement a public rights issue from authorized capital (2007 Authorized Capital) and decided to issue a capital increase for cash under protection of shareholder's subscription rights.

The Company's share capital is to be increased through the issue of up to 1,800,000 new no-per value bearer shares at a price of €1.00 per share. The new shares will increase the total number of issued and outstanding CyBio shares from 5,400,000 to 7,200,000.

CyBio shareholders will be granted an indirect subscription right. Any shares not subscribed by shareholders will be submitted to major shareholder Analytik Jena AG.

The expected cash inflow of approximately €1.8 million will strengthen the equity base and will provide CyBio with flexibility to successfully complete the initiated restructuring measures.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to